SARAVANAN RAMAKRISHNAN

Dr. SARAVANAN RAMAKRISHNAN

Indian Veterinary Research Institute, Bareilly, India
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Vaccine
Verified
Journal Article
Closed access
SSSwati Sachan
Swati Sachan
SRSARAVANAN RAMAKRISHNAN
SARAVANAN RAMAKRISHNAN
AAArunsaravanakumar Annamalai
Arunsaravanakumar Annamalai
BSBal Krishan Sharma
Bal Krishan Sharma
HMHina Malik
Hina Malik
NKNarayanan Krishnaswamy
Narayanan Krishnaswamy

1 March 2015 in Molecular Immunology
Verified
Journal Article
Closed access
SRSARAVANAN RAMAKRISHNAN
SARAVANAN RAMAKRISHNAN
AAArunsaravanakumar Annamalai
Arunsaravanakumar Annamalai
SSSwati Sachan
Swati Sachan
AKAnand Kumar
Anand Kumar
BSBal Krishan Sharma
Bal Krishan Sharma
NKNarayanan Krishnaswamy
Narayanan Krishnaswamy

26 September 2017 in Vaccines
Verified
Journal Article
Open access
PDF file
SDSohini Dey
Sohini Dey
MCMadhan Mohan Chellappa
Madhan Mohan Chellappa
DPDinesh C. Pathak
Dinesh C. Pathak
SGSatish S Gaikwad
Satish S Gaikwad
KYKalpana Yadav
Kalpana Yadav
VVVikram Vakharia
Vikram Vakharia
Newcastle disease virus (NDV) strain F is a lentogenic vaccine strain used for primary vaccination in day-old chickens against Newcastle disease (ND) in India and Southeast Asian countries. Recombinant NDV-F virus and another recombinant NDV harboring the major capsid protein VP2 gene of a very virulent infectious bursal disease virus (IBDV); namely rNDV-F and rNDV-F/VP2, respectively, were generated using the NDV F strain. The rNDV-F/VP2 virus was slightly attenuated, as compared to the rNDV-F virus, as evidenced from the mean death time and intracerebral pathogenicity index analysis. This result indicates that rNDV-F/VP2 behaves as a lentogenic virus and it is stable even after 10 serial passages in embryonated chicken eggs. When chickens were vaccinated with the rNDV F/VP2, it induced both humoral and cell mediated immunity, and was able to confer complete protection against very virulent IBDV challenge and 80% protection against virulent NDV challenge. These results suggest that rNDV-F could be an effective and inherently safe vaccine vector. Here, we demonstrate that a bivalent NDV-IBDV vaccine candidate generated by reverse genetics method is safe, efficacious and cost-effective, which will greatly aid the poultry industry in developing countries.

3 June 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KBKhalid Bashir
Khalid Bashir
DKDeepthi Kappala
Deepthi Kappala
YSYogendra Singh
Yogendra Singh
JDJaveed Ahmad Dar
Javeed Ahmad Dar
AMAsok Kumar Mariappan
Asok Kumar Mariappan
SRSARAVANAN RAMAKRISHNAN
SARAVANAN RAMAKRISHNAN
Live intermediate plus infectious bursal disease virus (IBDV) vaccines (hot vaccines) are used for protection against the virulent IBDV strains in young chickens. We evaluated the potential of Toll-like receptor (TLR) agonists to alleviate hot vaccine-induced immunosuppression. The combination of Pam3CSK4 and poly I:C synergistically upregulated IFN-β, IFN-γ, IL-12, IL-4, and IL-13 transcripts and cross-inhibited IL-1β, IL-10, and iNOS transcripts in the chicken peripheral blood mononuclear cells (PBMCs) as analyzed by quantitative real-time PCR. Further, four-week old specific pathogen free White Leghorn chickens (n = 60) were randomly divided into six groups and either immunized with hot IBDV vaccine with or without Pam3CSK4 and/or poly I:C or not vaccinated to serve as controls. The results indicated that poly I:C alone and in combination with Pam3CSK4 alleviated vaccine-induced immunosuppression, as evidenced by greater weight gain, increased overall antibody responses to both sheep erythrocytes and live infectious bronchitis virus vaccine, upregulated IFN-γ transcripts and nitric oxide production by PBMCs (P < 0.05), and lower bursal lesion score in the experimental birds. In conclusion, poly I:C alone and its combination with Pam3CSK4 reduced the destruction of B cells as well as bursal damage with restoration of function of T cells and macrophages when used with a hot IBDV vaccine.

10 September 2019 in Pathogens
Verified
Journal Article
Open access
PDF file
DSDeep Prakash Saikia
Deep Prakash Saikia
KYKalpana Yadav
Kalpana Yadav
DPDinesh C. Pathak
Dinesh C. Pathak
NRNARAYAN RAMAMURTHY
NARAYAN RAMAMURTHY
ADAjai Lawrence Dsilva
Ajai Lawrence Dsilva
SDSohini Dey
Sohini Dey
Newcastle disease (ND) and avian reovirus (ARV) infections are a serious threat to the poultry industry, which causes heavy economic losses. The mesogenic NDV strain R2B is commonly used as a booster vaccine in many Asian countries to control the disease. In this seminal work, a recombinant NDV strain R2B expressing the sigma C (σC) gene of ARV (rNDV-R2B-σC) was generated by reverse genetics, characterized in vitro and tested as a bivalent vaccine candidate in chickens. The recombinant rNDV-R2B-σC virus was attenuated as compared to the parent rNDV-R2B virus as revealed by standard pathogenicity assays. The generated vaccine candidate, rNDV-R2B-σC, could induce both humoral and cell mediated immune responses in birds and gave complete protection against virulent NDV and ARV challenges. Post-challenge virus shedding analysis revealed a drastic reduction in NDV shed, as compared to unvaccinated birds.

1 May 2016 in Veterinary Microbiology
Verified
Journal Article
Closed access
AAArunsaravanakumar Annamalai
Arunsaravanakumar Annamalai
SRSARAVANAN RAMAKRISHNAN
SARAVANAN RAMAKRISHNAN
SSSwati Sachan
Swati Sachan
BKB.S. Anand Kumar
B.S. Anand Kumar
BSBal Krishan Sharma
Bal Krishan Sharma
NKNarayanan Krishnaswamy
Narayanan Krishnaswamy